On the contrary however, Elibol et al. (2019) showed that in the case of AD thymoquinone did not change the level of TNF-α, IL-1α, and IL-1β groups with pretreatment of thymoquinone (Elibol et al., 2019). Here, IL1B is linked to Alzheimer disease.